Pharmaceutical group · Germany
Fresenius
A group of 53 companies with 1,470 medicines in 13 countries.
Loading your page…
Loading your page…
Pharmaceutical group · Germany
A group of 53 companies with 1,470 medicines in 13 countries.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
53 companies in 20 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 1,470
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| 0.9% SODIUM CHLORIDE INJECTION900 mg / 100 ml · Solution | Sodium chloride | Canada | Marketed | 2013 |
| 2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION20 mg / ml · Solution | Calcium gluconate | Canada | Marketed | 2025 |
| 5% DEXTROSE INJECTION50 mg / ml · Solution | Dextrose | Canada | Marketed | 2014 |
| ACETAMINOPHEN1gm/100ml (10mg/ml) | 500mg/50ml (10mg/ml) | 650mg/65ml (10mg/ml) · Solution | Paracetamol | United States | Marketed | 2015 |
| ACETATO SODICO 1M FRESENIUS KABI CONCENTRADO PARA SOLUCION PARA PERFUSION1361 mg · Solución inyectable | Sodium acetate | Spain | Marketed | 2001 |
| ácido zoledrônico | Zoledronic acid | Brazil | Authorised | 2019 |
| ACIDO ZOLEDRONICO FRESENIUS KABIConcentrato per soluzione per infusione | Zoledronic acid | Italy | Authorised | |
| ACIDO ZOLEDRONICO KABI 4MG/5ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG0,80 mg · Concentrado para solución para perfusión | Zoledronic acid | Spain | Marketed | 2013 |
| ACQUA PER PREPARAZIONI INIETTABILI FKISoluzione iniettabile | Acqua preparazioni iniettabili | Italy | Authorised | |
| ACQUA PER PREPARAZIONI INIETTABILI FKISoluzione iniettabile | Acqua preparazioni iniettabili | Italy | Authorised | |
| ACYCLOVIR SODIUM INJECTION50 mg / ml · Solution | Aciclovir | Canada | Marketed | 1998 |
| ADDAMEL NConcentrato per soluzione per infusione | Cromo, Rame, Ferrous, Manganese, Potassio ioduro, Fluoride, Technetium (99m tc) pertechnetate, Selenium, Zinc | Italy | Authorised | |
| ADDAVEN | Cloreto zinco, Cloreto férrico, Fluoreto, Cloreto cúprico, Dicloreto manganês, Selenium, Iodeto, Cloreto crômico, Technetium (99m tc) pertechnetate | Brazil | Authorised | 2020 |
| ADDAVEN CONCENTRATE FOR SOLUTION FOR INFUSION5.33 mcg/ml + 102.3 mcg/ml + 540 mcg/ml + 19.79 mcg/ml + 16.6 mcg/ml + 210 mcg/ml + 4.85 mcg/ml + 17.29 mcg/ml + 1050 mcg/ml · Infusion, solution concentrate | Chromic, Copper, Ferric citrate, Manganese, Potassium iodide, Fluoride, Technetium (99m tc) pertechnetate, Selenium, Zinc | Singapore | Authorised | 2017 |
| ADDNUTRIV10 mcg / 10 ml + 380 mcg / 10 ml + 950 mcg / 10 ml + 130 mcg / 10 ml + 1100 mcg / 10 ml + 55 mcg / 10 ml + 19 mcg / 10 ml + 79 mcg / 10 ml + 5000 mcg / 10 ml · Solution | Chromium, Copper, Fluoride, Iodine, Iron, Manganese, Molybdenum, Selenium, Zinc | Canada | Marketed | 2020 |
| ADENOSINA KABISoluzione iniettabile | Adenosine | Italy | Authorised | |
| ADENOSINA KABI 3 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA3 mg · Solución inyectable en jeringa precargada | Adenosine | Spain | Marketed | 2017 |
| Adenosine Fresenius Kabi 3 mg/ml, oplossing voor injectie in een voorgevulde spuitOplossing voor injectie | Adenosine | Netherlands | Authorised | 2015 |
| ADENOSINE INJECTION3 mg / ml · Solution | Adenosine | Canada | Marketed | 2017 |
| ADENOSINE INJECTION3 mg / ml · Solution | Adenosine | Canada | Marketed | 2017 |
| ADENOSINE INJECTION3 mg / ml · Solution | Adenosine | Canada | Marketed | 2007 |
| ADRIM – DOXORUBICIN HYDROCHLORIDE INJECTION USP 2MG/ML2 mg/ml · Injection, solution | Doxorubicin | Singapore | Authorised | 2021 |
| ÁGUA PARA INJEÇÃO | Água para injetáveis, Água para injeção | Brazil | Authorised | 2004 |
| AGUA PARA PREPARACIONES INYECTABLES FRESENIUS KABI DISOLVENTE PARA USO PARENTERAL100 ml · Disolvente para uso parenteral | Agua para preparaciones inyectables | Spain | Marketed | 2001 |
| AGUA PARA PREPARACIONES INYECTABLES MEINSOL, DISOLVENTE PARA USO PARENTERAL100 ml · Disolvente para uso parenteral | Agua para preparaciones inyectables | Spain | Marketed | 1990 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 223 | 167 | 56 | CompaniesAll medicines |
| Spain | 212 | 161 | 51 | CompaniesAll medicines |
| Brazil | 198 | 71 | 127 | CompaniesAll medicines |
| Netherlands | 188 | 188 | 0 | CompaniesAll medicines |
| United States | 138 | 136 | 2 | CompaniesAll medicines |
| Serbia | 115 | 107 | 8 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
| Romania | 97 | 0 | 97 | CompaniesAll medicines |
|---|
| Italy | 92 | 92 | 0 | CompaniesAll medicines |
|---|
| Croatia | 69 | 69 | 0 | CompaniesAll medicines |
|---|
| Singapore | 67 | 67 | 0 | CompaniesAll medicines |
|---|
| Saudi Arabia | 32 | 32 | 0 | CompaniesAll medicines |
|---|
| Taiwan | 26 | 7 | 19 | CompaniesAll medicines |
|---|
| European Union (EMA) | 13 | 12 | 1 | CompaniesAll medicines |
|---|
Also in the registers of France, United Kingdom
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
INSEE (www.insee.fr), via DINUM API Recherche d’entreprises; include original record update date and retrieval date
Licence: Licence Ouverte / Open Licence
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licence: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Contains Irish Public Sector Data licensed under Creative Commons Attribution 4.0 International (CC BY 4.0), Companies Registration Office; original dataset/API URL and company number, exact locator/source version and retrieval date; selected field normalization by Prognia. https://creativecommons.org/licenses/by/4.0/
Licence: Creative Commons Attribution
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licence: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence: Italian Open Data Licence
State Enterprise Centre of Registers / Valstybės įmonė Registrų centras; source dataset/resource URL, exact original code/UUID/revision, original CSV ordinal, retrieval time; CC BY 4.0 https://creativecommons.org/licenses/by/4.0/ ; selected field normalization by Prognia.
Licence: Creative Commons Attribution
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Licence: Norwegian Licence for Open Government Data
Ministerstwo Sprawiedliwości / Krajowy Rejestr Sądowy; original source URL, literal IDs and source locators, original creation/snapshot dates where present and acquisition time; selected fields normalized by Prognia; original statutory/MOJ reuse conditions
Licence: Statutory public-register API reuse with attribution conditions
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
TFDA, dataset 9122, Government Open Data Licence 1.0; source update and retrieval dates
Licence: Taiwan Government Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.